ADC Therapeutics to Share New Data on LOTIS-7 Tria...
Category : Clinical Trial Update 3 December 2025ADC Therapeutics is preparing to reveal fresh clinical insights on its ongoing LOTIS-7 Phase 1b tria...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
EMA’s Positive PIP Decision Clears New Path for AO...
Category : Clinical Trial Update 3 December 2025AOB Pharma, Inc. (AOBiome) has secured a major regulatory milestone for its lead topical therapeutic...
FDA Expands Dosing Options for OMLYCLO: What the N...
Category : Approval/Launch 3 December 2025The FDA has approved a new 300 mg/2 mL prefilled syringe presentation of OMLYCLO® (omalizumab-ig...
AbbVie’s Atogepant Hits Key Milestones in Phase 3...
Category : Clinical Trial Update 2 December 2025AbbVie has reported strong preliminary results from its pivotal Phase 3 ECLIPSE trial, showing that...
Generate:Biomedicines Advances GB-0895 Into Phase...
Category : Clinical Trial Update 2 December 2025Generate:Biomedicines just moved one step closer to reshaping respiratory medicine. The company is...
Latest Newsletter Post
-
FDA Expands Dosing Options for OMLY..
3 December 2025
-
EMA’s Positive PIP Decision Clears..
3 December 2025
-
ADC Therapeutics to Share New Data..
3 December 2025
-
Spinogenix Secures INN Approval for..
2 December 2025
-
Generate:Biomedicines Advances GB-0..
2 December 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com